A new study finds that combining the current medications for Alzheimer’s disease with small molecules derived from micronutrients found in grapes, berries, peanuts and turmeric is a safer and more effective way to treat the disease.
Volume 35 of the Medicinal Chemistry Research journal cover features art compiled by University of Waterloo School of Pharmacy student Rahul Karuturi (PhD’25) for their research, Synthesis and evaluation of symmetric (1,4-diazepane-1,4-diyl)bis(phenylmethanone) derivatives as amyloid-beta aggregation inhibitors.
The 19th issue of the Nanoscale Advances Journal features art compiled by University of Waterloo School of Pharmacy Mohamed Aborig (PhD’25) for their research, Engineered dual-functional gold nanoparticles enhance radiosensitization in prostate cancer cells: synergistic action of curcumin and gold.
Researchers from the School of Pharmacy at the University of Waterloo use a modified version of a bacterial virus called M13 to target specific human cells to deliver different therapeutic genes for the treatment of many different diseases.
Despite an overall decline in prescribed opioid use in Canada over the past decade, a recent study by researchers from the School of Pharmacy at the University of Waterloo, found that people in poorer areas receive three times the prescriptions for opioids than those in wealthier areas.
The fourth issue of ACS Medicinal Chemistry Letters Journal features art compiled by University of Waterloo School of Pharmacy PhD student Ahmed Hefny for their research, Novel Phenoselenazines as Amyloid-β Aggregation Inhibitors.
A new mathematical model developed at the University of Waterloo School of Pharmacy can determine a baby’s overall drug exposure when their mother is taking medication.
Researchers from Waterloo Pharmacy have developed a new technology that can hold an entire course of antibiotics in one tiny dose and deliver on demand just the right amount of medication that a particular patient needs to fight an infection.
Waterloo PhD candidate, Mira Maximos, investigates sex, gender and the regulation of prescription drugs
Canada will not reach the original World Health Organization's (WHO) target of eliminating the Hepatitis C virus (HCV) by 2030 and lags in comparison to other developed countries, a new study led by researchers at the University of Waterloo has found.